Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01563276 · ClinicalTrials.gov registry record

Postural Instability in Progressive Supranuclear Palsy

A clinical trial, sponsored by Oregon Health and Science University.

Completed
Registry status
36
Enrollment target

NCT01563276 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01563276 has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
36 participants
Enrollment target

Study Summary

The purpose of this study is to better understand why individuals with Progressive Supranuclear Palsy (PSP) fall. Understanding the mechanism of gait and balance dysfunction in individuals with PSP may provide us with important early diagnostic tools, allowing for earlier identification of mobility problems and to better evaluate medical therapies aimed at improving motor disability. The investigators will recruit 10 PSP, 10 PD and 10 healthy controls for the study. All subjects will be asked to come to the OHSU clinic at the Center for Health and Healing for an initial screening visit. They will meet with the primary investigator to conduct a brief interview and physical examination. In addition, they will be asked to answer questions regarding current and past medical illness, how often they fall and what kinds of medications they are on. Subjects who agree to participate will come to the Oregon Clinical and Translational Research Institute (OCTRI) at OHSU for balance testing. Subjects will be asked to stand or sit on a movable platform with eyes open or closed. Prior to standing on the platform, the investigators will place 6 small sensors on body which are held in place by velcro straps (one on each wrist, ankles, chest and lower back). The platform will then be moved (tilt or slide) while subjects try to keep their balance. During all of the balance tests described above, body movements will be recorded from the sensors on the subjects' body. This data is directly recorded by a computer and analyzed to help us gain better understanding of the subjects' posture and their ability to remain up right.

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2011-12
Est. Completion 2013-05-10

What the Registry Record Tells You About NCT01563276

The ClinicalTrials.gov registry entry for NCT01563276 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01563276 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01563276 about?

NCT01563276 is a clinical study titled "Postural Instability in Progressive Supranuclear Palsy". The purpose of this study is to better understand why individuals with Progressive Supranuclear Palsy (PSP) fall. Understanding the mechanism of gait and balance dysfunction in individuals with PSP may provide us with important early diagnostic tools, allowing for earlier identification of mobility ...

What is the current status of trial NCT01563276?

This trial is currently completed. The enrollment target is 36 participants. The study started on 2011-12. Estimated completion is 2013-05-10.

Who is sponsoring clinical trial NCT01563276?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.